Institutional Ownership
Zura Bio Ltd
CUSIP G9TY5A101CLASS A ORD SHSZURAQ1 2026
13D / 13G Filings
39
Schedule 13D/13G on record
Beneficial Filers
20
Distinct reporting persons
Largest Stake
19.9%
Max % of class reported
Institutional Holders
90
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
39 filings · latest Mar 2, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Mar 2, 2026 | Ai Biotechnology LLC | 13D/A | 18.2% | — | SEC |
| 2 | Feb 17, 2026 | Great Point Partners, LLC | 13G/A | 5.2% | 3.82M | SEC |
| 3 | Feb 13, 2026 | Suvretta Capital Management, LLC | 13G/A | 8.6% | 5.57M | SEC |
| 4 | Jan 27, 2026 | Athanor Capital | 13D | 15.7% | — | SEC |
| 5 | Jan 2, 2026 | Athanor Capital | 13G | 15.7% | 11.58M | SEC |
| 6 | Nov 14, 2025 | Great Point Partners, LLC | 13G/A | 5.9% | 3.82M | SEC |
| 7 | Nov 14, 2025 | Deep Track Capital, LP | 13G/A | 0.4% | 259.0K | SEC |
| 8 | Aug 14, 2025 | Venrock Healthcare Capital Partners III, L.P. | 13G/A | 9.9% | 6.35M | SEC |
| 9 | Aug 14, 2025 | Deep Track Capital, LP | 13G/A | 7.1% | 4.62M | SEC |
| 10 | Jul 16, 2025 | Jpmorgan Chase &Amp; Co. | 13G | 7.5% | 4.67M | SEC |
29 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Zura Bio Ltd.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Suvretta Capital Management, LLC | 9.07M | $53.95M |
| 2 | Venrock Adviser, LLC | 6.43M | $38.29M |
| 3 | Jpmorgan Chase & Co | 4.46M | $25.33M |
| 4 | Great Point Partners LLC | 4.22M | $25.08M |
| 5 | Braidwell LP | 3.99M | $23.73M |
| 6 | Siren, L.L.C. | 3.73M | $22.22M |
| 7 | Commodore Capital LP | 3.25M | $19.34M |
| 8 | Pfizer Inc | 2.84M | $16.83M |
| 9 | Adage Capital Partners Gp, L.L.C. | 2.75M | $16.36M |
| 10 | Affinity Asset Advisors, LLC | 2.56M | $15.26M |